Published in Thromb Res on November 01, 2001
Platelet adhesion from shear blood flow is controlled by near-wall rebounding collisions with erythrocytes. Biophys J (2011) 1.04
Development of a perfusion chamber assay to study in real time the kinetics of thrombosis and the antithrombotic characteristics of antiplatelet drugs. Thromb J (2012) 0.84
Platelet-derived NO slows thrombus growth on a collagen type III surface. Thromb J (2004) 0.83
Effects of the selective inhibition of platelet thromboxane synthesis on the platelet-subendothelium interaction. Br J Pharmacol (2002) 0.77
Effects of Rivaroxaban on Platelet Activation and Platelet-Coagulation Pathway Interaction: In Vitro and In Vivo Studies. J Cardiovasc Pharmacol Ther (2015) 0.76
The impact of blood shear rate on arterial thrombus formation. Future Sci OA (2015) 0.76
Biomarkers and Bioassays for Cardiovascular Diseases: Present and Future. Biomark Insights (2008) 0.75
Anti-GPVI Fab SAR264565 effectively blocks GPVI function in ex vivo human platelets under arterial shear in a perfusion chamber. Eur J Clin Pharmacol (2017) 0.75
Age-related changes in human lens crystallins identified by two-dimensional electrophoresis and mass spectrometry. Exp Eye Res (1998) 1.88
Experimental acute thrombotic stroke in baboons. Stroke (1987) 1.64
Localizing antithrombotic and vasodilatory activity with a novel, ultrafast nitric oxide donor. J Med Chem (1996) 1.54
Age-related changes in human lens crystallins identified by HPLC and mass spectrometry. Exp Eye Res (1998) 1.53
Inhibition of thrombus formation by activated recombinant protein C in a primate model of arterial thrombosis. Circulation (1990) 1.52
Antithrombotic effects of combining activated protein C and urokinase in nonhuman primates. Circulation (1991) 1.47
Antithrombotic activity of protein S infused without activated protein C in a baboon thrombosis model. Thromb Haemost (2012) 1.42
Mechanisms of arterial graft failure. 1. Role of cellular proliferation in early healing of PTFE prostheses. Am J Pathol (1985) 1.40
Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement. Blood (1985) 1.18
Inhibition of platelet-dependent thrombosis by low molecular weight heparin (CY222): comparison with standard heparin. J Lab Clin Med (1989) 1.14
Beta3 integrins are upregulated after vascular injury and modulate thrombospondin- and thrombin-induced proliferation of cultured smooth muscle cells. Circulation (1998) 1.12
Platelet reactivity in depressed patients treated with paroxetine: preliminary findings. Arch Gen Psychiatry (2000) 1.12
Oligomerization and phase separation in globular protein solutions. Biophys Chem (1998) 1.10
A mechanistic model of acute platelet accumulation in thrombogenic stenoses. Ann Biomed Eng (2001) 1.08
Inhibition of platelet-dependent thrombus formation by human activated protein C in a primate model. Blood (1989) 1.08
Induction of vascular endothelial growth factor in balloon-injured baboon arteries. A novel role for reactive oxygen species in atherosclerosis. Circ Res (1997) 1.06
Nitric oxide-releasing polymers containing the [N(O)NO]- group. J Med Chem (1996) 1.05
In vivo evaluation of artificial surfaces with a nonhuman primate model of arterial thrombosis. J Lab Clin Med (1980) 1.00
Platelet interactions with Dacron vascular grafts. A model of acute thrombosis in baboons. Arteriosclerosis (1985) 0.99
Reduced thrombus formation by hyaluronic acid coating of endovascular devices. Arterioscler Thromb Vasc Biol (2000) 0.98
A scaling law for wall shear rate through an arterial stenosis. J Biomech Eng (1994) 0.96
The role of alpha and beta platelet-derived growth factor receptor in the vascular response to injury in nonhuman primates. Arterioscler Thromb Vasc Biol (1999) 0.96
Interruption of vascular thrombus formation and vascular lesion formation by dietary n-3 fatty acids in fish oil in nonhuman primates. Circulation (1993) 0.96
Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition. J Clin Invest (1985) 0.95
Dose-response effects of pegylated human megakaryocyte growth and development factor on platelet production and function in nonhuman primates. Blood (1996) 0.95
Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates. Circulation (1998) 0.94
Experimental arterial thromboembolism in baboons. Mechanism, quantitation, and pharmacologic prevention. J Clin Invest (1979) 0.94
Antithrombotic strategies targeting thrombin activities, thrombin receptors and thrombin generation. Thromb Haemost (1997) 0.91
Bileaflet aortic valve prosthesis pivot geometry influences platelet secretion and anionic phospholipid exposure. Ann Biomed Eng (2001) 0.91
The relation of platelet density to platelet age: survival of low- and high-density 111indium-labeled platelets in baboons. Blood (1986) 0.90
Hirudin interruption of heparin-resistant arterial thrombus formation in baboons. Blood (1991) 0.90
Limited generation of activated protein C during infusion of the protein C activator thrombin analog W215A/E217A in primates. J Thromb Haemost (2006) 0.90
Regulation of platelet production and function by megakaryocyte growth and development factor in nonhuman primates. Blood (1996) 0.90
Characterization of thrombin receptor expression during vascular lesion formation. Circ Res (1994) 0.90
Phosphorylcholine coating of ePTFE grafts reduces neointimal hyperplasia in canine model. Ann Vasc Surg (1997) 0.90
Enhanced thrombolytic and antithrombotic potency of a fibrin-targeted plasminogen activator in baboons. Circulation (1996) 0.90
Healing of polytetrafluoroethylene arterial grafts is influenced by graft porosity. J Vasc Surg (1990) 0.89
On the multiplicity of platelet prostaglandin receptors. II. The use of N-0164 for distinguishing the loci of action for PGI2, PGD2, PGE2 and hydantoin analogs. Prostaglandins (1984) 0.89
Prevention of acquired transient defect in platelet plug formation by infused prostacyclin. Blood (1981) 0.88
A novel method for efficient drug delivery. Ann Biomed Eng (1998) 0.87
Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo. J Lab Clin Med (1989) 0.87
Enhanced in vivo antithrombotic effects of endothelial cells expressing recombinant plasminogen activators transduced with retroviral vectors. Circulation (1996) 0.86
Pharmacokinetic studies of standard unfractionated heparin, and low molecular weight heparins in the rabbit. Semin Thromb Hemost (1988) 0.86
Relative antithrombotic effects of monoclonal antibodies targeting different platelet glycoprotein-adhesive molecule interactions in nonhuman primates. Blood (1994) 0.85
Phosphorylcholine coating of ePTFE reduces platelet deposition and neointimal hyperplasia in arteriovenous grafts. J Surg Res (1998) 0.85
Antithrombotic effects of synthetic peptides targeting various functional domains of thrombin. Proc Natl Acad Sci U S A (1992) 0.85
Boundary layer infusion of nitric oxide reduces early smooth muscle cell proliferation in the endarterectomized canine artery. J Surg Res (1997) 0.84
Local infusion of heparin reduces anastomotic neointimal hyperplasia in aortoiliac expanded polytetrafluoroethylene bypass grafts in baboons. J Vasc Surg (2000) 0.84
Antithrombotic and antilesion benefits without hemorrhagic risks by inhibiting tissue factor pathway. Haemostasis (1996) 0.84
Relationship between endothelial tissue factor and thrombogenesis under blood flow conditions. Thromb Haemost (1995) 0.84
Eptifibatide-induced thrombocytopenia and coronary bypass operation. J Thromb Haemost (2003) 0.84
In vitro endothelialization of small-caliber vascular grafts. Surgery (1987) 0.84
Effects of red blood cell concentration on hemostasis and thrombus formation in a primate model. Blood (1990) 0.83
Correlation between prolonged bleeding time and depletion of platelet dense granule ADP in patients with myelodysplastic and myeloproliferative disorders. J Lab Clin Med (1984) 0.83
Cross-reactivity of human molecular markers for detection of prethrombotic states in various animal species. Blood Coagul Fibrinolysis (1995) 0.83
Monoclonal antibody-induced inhibition of platelet function: effects on hemostasis and vascular graft thrombosis in baboons. J Vasc Surg (1988) 0.83
Blood and tissue compatibility of modified polyester: thrombosis, inflammation, and healing. J Biomed Mater Res (1998) 0.83
The sensitivity of indicators of thrombosis initiation to a bileaflet prosthesis leakage stimulus. J Heart Valve Dis (2001) 0.82
Factor V turnover in a primate model. Blood (1995) 0.82
Boundary layer infusion of basic fibroblast growth factor accelerates intimal hyperplasia in endarterectomized canine artery. J Surg Res (1997) 0.82
RGDV peptide selectively inhibits platelet-dependent thrombus formation in vivo. Studies using a baboon model. J Clin Invest (1989) 0.82
A new method for quantifying platelet deposition in flowing native blood in an ex vivo model of human thrombogenesis. Thromb Haemost (1998) 0.81
Studies of suloctidil in experimental thrombosis in baboons. Thromb Haemost (1985) 0.81
Thrombin hypothesis of thrombus generation and vascular lesion formation. Am J Cardiol (1995) 0.81
Biotinylated platelets: a new approach to the measurement of platelet life span. Br J Haematol (1993) 0.81
Anti-VLA-4 antibody reduces intimal hyperplasia in the endarterectomized carotid artery in nonhuman primates. J Vasc Surg (1997) 0.81
In vivo and in vitro complexes of activated protein C with two inhibitors in baboons. Blood (1991) 0.80
Antithrombotic effects of ionic and non-ionic contrast media in nonhuman primates. Thromb Haemost (2001) 0.80
Confluent durable endothelialization of endarterectomized baboon aorta by early attachment of cultured endothelial cells. J Vasc Surg (1990) 0.80
Local delivery of an antithrombin inhibits platelet-dependent thrombosis. Circulation (1994) 0.80
Selective inhibition by a synthetic hirudin peptide of fibrin-dependent thrombosis in baboons. Proc Natl Acad Sci U S A (1991) 0.80
Pharmacokinetics of dermatan sulfate in the rabbit after intravenous injection. Thromb Haemost (1988) 0.79
Autologous platelet kinetics in patients with severe thrombocytopenia: discrimination between disorders of production and destruction. J Lab Clin Med (1991) 0.79
Induction of transient neurological dysfunction in baboons by platelet microemboli. Stroke (1992) 0.79
Blood compatibility of surfaces modified by plasma polymerization. J Biomed Mater Res (1988) 0.79
Antithrombotic benefits and hemorrhagic risks of direct thrombin antagonists. Thromb Haemost (1995) 0.79
Panel conference. Blood-materials interactions - 20 years of frustration. Trans Am Soc Artif Intern Organs (1981) 0.79
Local delivery of a synthetic antithrombin with a hydrogel-coated angioplasty balloon catheter inhibits platelet-dependent thrombosis. J Am Coll Cardiol (1994) 0.79
Interruption of vascular thrombosis by bolus anti-platelet glycoprotein IIb/IIIa monoclonal antibodies in baboons. J Vasc Surg (1993) 0.79
Effect of blood flow on thrombin generation is dependent on the nature of the thrombogenic surface. Blood (1994) 0.79
Lasting safe interruption of endarterectomy thrombosis by transiently infused antithrombin peptide D-Phe-Pro-ArgCH2Cl in baboons. Blood (1993) 0.78
Prevention of heparin-resistant thrombotic occlusion of hollow-fiber hemodialyzers by synthetic antithrombin. J Lab Clin Med (1989) 0.78
Is smooth muscle growth in primate arteries regulated by endothelial nitric oxide synthase? J Vasc Surg (1998) 0.78
Preformed confluent endothelial cell monolayers prevent early platelet deposition on vascular prostheses in baboons. J Vasc Surg (1988) 0.78
Nonporous silicone polymer coating of expanded polytetrafluoroethylene grafts reduces graft neointimal hyperplasia in dog and baboon models. J Vasc Surg (1996) 0.78
Antithrombotic efficacy of the vitamin K antagonist fluindione in a human Ex vivo model of arterial thrombosis : effect of anticoagulation level and combination therapy with aspirin. Arterioscler Thromb Vasc Biol (1999) 0.78
The kinetics of baboon fibrinogen adsorption to polymers: in vitro and in vivo studies. J Biomed Mater Res (1986) 0.78
Experimental arterial thrombosis in nonhuman primates. Circulation (1991) 0.78
Thromboembolic potential of synthetic vascular grafts in baboons. J Vasc Surg (1989) 0.78
Reduction in stent and vascular graft thrombosis and enhancement of thrombolysis by recombinant Lys-plasminogen in nonhuman primates. Circulation (1997) 0.78
A comparative study of the anticoagulant and anti-thrombotic effects of unfractionated heparin and a low molecular weight heparin (Fraxiparine) in an experimental model of human venous thrombosis. Thromb Haemost (1995) 0.77
Iliac artery mural thrombus formation. Effect of antiplatelet therapy on 111In-platelet deposition in baboons. Arteriosclerosis (1986) 0.77
Inhibition of platelet-dependent thrombosis by local delivery of heparin with a hydrogel-coated balloon. Circulation (1995) 0.77
D-dimer levels in patients with long-term antecedents of deep venous thrombosis. Thromb Haemost (1994) 0.77
Antihemostatic and antithrombotic effects of monoclonal antibodies against von Willebrand factor in nonhuman primates. Surgery (1992) 0.77
Recombinant mitotoxin basic fibroblast growth factor-saporin reduces venous anastomotic intimal hyperplasia in the arteriovenous graft. Circulation (1996) 0.77